Close

Clinical Trials

Early trials find Russia’s Sputnik V safe, volunteers develop coronavirus antibodies within 3 weeks

Much buzz was created around the world when Russia claimed to have approved the first COVID-19 vaccine around the world, for public use. Experts...

Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate

Sanofi and GSK today started the Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine. The vaccine candidate, developed in partnership by Sanofi and...

Clinerion and Maxer Consulting partner to boost the identification and the recruitment of patients into clinical trials in Italy

Clinerion's Patient Network Explorer will leverage Maxer's extended network of relations in the international healthcare sector to access promising business opportunities and expand Clinerion’s...

Bayer submits vericiguat for marketing authorization in China for the treatment of chronic heart failure

Bayer announced the submission of the regulatory application seeking the approval of vericiguat in China. Vericiguat is an investigational oral, once-daily, first-in-class soluble guanylate...

Oxford Covid-19 vaccine: Serum Institute begins clinical trial in India

Serum Institute of India’s trial for ‘Covishield’ vaccine developed by the University of Oxford started with the first patients screened by Bharati Vidyapeeth Deemed...

Australian COVID-19 vaccine shows promising results in animal trials

A COVID-19 vaccine candidate being developed by Australia’s University of Queensland has shown “positive” results against the novel coronavirus in preclinical tests, raising hopes...

Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials

Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, announced a partnership with Clinerion, a worldwide leader in medical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read